About Conference
The Best of Hematology and Breast Cancer 2025 conference in Seattle is a CME-accredited, in-person event providing healthcare professionals with the latest updates in managing hematology and breast cancer. Drawing insights from the 66th ASH Annual Meeting (ASH24) and the San Antonio Breast Cancer Symposium (SABCS24), the conference features expert presentations on recent research and its clinical implications.
Highlights
Summarize the latest updates from ASH24 and SABCS24, focusing on their implications for clinical practice in managing hematologic disorders and breast cancer, Assess new therapeutic options for benign and malignant hematologic disorders and breast cancer, including appropriate indications and contraindications presented at ASH24 and SABCS24,
Find on Map
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
How access to specialized cancer centers affects glioblastoma outcomes
2.
Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists
3.
Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.
4.
U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Pain
5.
Beyond What Is Visible in Myelofibrosis?
1.
Beyond the Biopsy: Decoding Tumor Biology Through the Lens of Radiogenomics
2.
The Millionaire's Battle: Does Mark Cuban Have Cancer?
3.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
4.
Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction
5.
Octreotide's Efficacy in Reducing Transfusion Requirements in Angiodysplasia Bleeding
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Advances in Modern Cancer Treatment
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
3.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
5.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
Recommended News For You
1.
Headlines About Doc Who 'Catches' Patient's Cancer Are Popping Up Again
2.
e-Cigarettes and Lung Cancer: Is Harm Reduction Overstated?
3.
Smoldering Myeloma: The Treatment Issue Is Getting Trickier
4.
An inoperable locally advanced NSCLC trial dubbed "Practice Changing".
5.
The top three drugs for multiple myeloma treatment upfront are four.
Conferences That Might Interest You
Recommended Articles For You
1.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
2.
Hematopoietic Aging and Functional Blood Health: Mechanisms, Clinical Implications, and Advances
3.
Clinical Guidelines for Monitoring Bone Marrow Functional Reserve
4.
Emerging Methods in Hematology in Clinical Decision-Making
5.
Precision Oncology: How Personalized Medicine is Transforming Cancer Treatment
Boost Your Knowledge With These Quizzes
1.
Quiz On Tonsillitis Management
2.
Quiz on Precision Nutrition in Endocrinology: Unlocking the Genetic Code for Diet Therapy
3.
Quiz on Hepatitis B Virus Transmission, Diagnosis, Treatment and Prevention
4.
Quiz on Chlorhexidine in Dentistry
5.
Quiz on Innovative Therapies for Osteoporosis in Postmenopausal Women: How Well Do You Know the Latest Advances?
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge